암 치료용 TLR7 효능제 및 조합들

본 개시는 특이적 TLR7 효능제 BNT411, 예컨대, BNT411을 포함하는 조성물 및 키트, 및 종양, 특히, 고형 종양의 진행을 감소시키거나 방지하거나 암, 특히, 고형 암을 치료하기 위한 단일 요법 및 병용 요법에서의 면역치료제로서의 BNT411의 용도에 관한 것이다. The present disclosure relates to the specific TLR7 agonist BNT411, such as compositions and kits comprising BNT411, and the use of BNT411 as im...

Full description

Saved in:
Bibliographic Details
Main Authors HASSAN HARIZ ISKANDAR BIN, SAHIN UGUR, ROSEMANN ROMAN, STROBL STEFAN
Format Patent
LanguageKorean
Published 27.06.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 본 개시는 특이적 TLR7 효능제 BNT411, 예컨대, BNT411을 포함하는 조성물 및 키트, 및 종양, 특히, 고형 종양의 진행을 감소시키거나 방지하거나 암, 특히, 고형 암을 치료하기 위한 단일 요법 및 병용 요법에서의 면역치료제로서의 BNT411의 용도에 관한 것이다. The present disclosure relates to the specific TLR7 agonist BNT411, such as compositions and kits comprising BNT411, and the use of BNT411 as immunotherapeutic agent in monotherapy and combination therapy to reduce or prevent progression of a tumor, in particular a solid tumor, or treating cancer, in particular a solid cancer.
AbstractList 본 개시는 특이적 TLR7 효능제 BNT411, 예컨대, BNT411을 포함하는 조성물 및 키트, 및 종양, 특히, 고형 종양의 진행을 감소시키거나 방지하거나 암, 특히, 고형 암을 치료하기 위한 단일 요법 및 병용 요법에서의 면역치료제로서의 BNT411의 용도에 관한 것이다. The present disclosure relates to the specific TLR7 agonist BNT411, such as compositions and kits comprising BNT411, and the use of BNT411 as immunotherapeutic agent in monotherapy and combination therapy to reduce or prevent progression of a tumor, in particular a solid tumor, or treating cancer, in particular a solid cancer.
Author SAHIN UGUR
ROSEMANN ROMAN
HASSAN HARIZ ISKANDAR BIN
STROBL STEFAN
Author_xml – fullname: HASSAN HARIZ ISKANDAR BIN
– fullname: SAHIN UGUR
– fullname: ROSEMANN ROMAN
– fullname: STROBL STEFAN
BookMark eNrjYmDJy89L5WTQejN1isKbnTNeL-55M2ulQohPkLnC21krXnctfbNgjsLrDf0KbxZueDt15evJS3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbx3kJGBkYmBgaW5hbGxozFxqgD79DVA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20240097833A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20240097833A3
IEDL.DBID EVB
IngestDate Fri Sep 27 05:30:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20240097833A3
Notes Application Number: KR20247013205
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240627&DB=EPODOC&CC=KR&NR=20240097833A
ParticipantIDs epo_espacenet_KR20240097833A
PublicationCentury 2000
PublicationDate 20240627
PublicationDateYYYYMMDD 2024-06-27
PublicationDate_xml – month: 06
  year: 2024
  text: 20240627
  day: 27
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies BIONTECH SE
RelatedCompanies_xml – name: BIONTECH SE
Score 3.5023925
Snippet 본 개시는 특이적 TLR7 효능제 BNT411, 예컨대, BNT411을 포함하는 조성물 및 키트, 및 종양, 특히, 고형 종양의 진행을 감소시키거나 방지하거나 암, 특히, 고형 암을 치료하기 위한 단일 요법 및 병용 요법에서의 면역치료제로서의 BNT411의 용도에 관한 것이다. The...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 암 치료용 TLR7 효능제 및 조합들
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240627&DB=EPODOC&locale=&CC=KR&NR=20240097833A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFLTDU2SzTRtUwxMtM1STZJ1U00TEvRtUgySTYzM7VMSkwGL5D1M_MINfGKMI1gYsiB7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuatDeMah6MjJXc3GydQ3wd_F3VnN2tvUOUvMLgsiB9ywYOzIzsAIb0uag_OAa5gTal1KAXKm4CTKwBQDNyysRYmDKzhdm4HSG3b0mzMDhC53yBjKhua9YhEHrzdQpCm92zni9uOfNrJUKIT5B5gpvZ6143bX0zYI5Cq839Cu8Wbjh7dSVrycvEWVQdnMNcfbQBVoaD_djvHcQsguNxRhYgL3_VAkGhdTUVOMko2QzY0OTNBMzMyNLA2Ngly4lzcAsydgyzSxJkkEGn0lS-KWlGbhAXNDaJyNzGQaWkqLSVFlgLVuSJAcOHADQVYl3
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTFLTDU2SzTRtUwxMtM1STZJ1U00TEvRtUgySTYzM7VMSkwGL5D1M_MINfGKMI1gYsiB7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuatDeMah6MjJXc3GydQ3wd_F3VnN2tvUOUvMLgsiB9ywYOzIzsAIb2eag_OAa5gTal1KAXKm4CTKwBQDNyysRYmDKzhdm4HSG3b0mzMDhC53yBjKhua9YhEHrzdQpCm92zni9uOfNrJUKIT5B5gpvZ6143bX0zYI5Cq839Cu8Wbjh7dSVrycvEWVQdnMNcfbQBVoaD_djvHcQsguNxRhYgL3_VAkGhdTUVOMko2QzY0OTNBMzMyNLA2Ngly4lzcAsydgyzSxJkkEGn0lS-KXlGTg9Qnx94n08_bylGbhAUqB1UEbmMgwsJUWlqbLAGrckSQ4cUABtkYxq
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EC%95%94+%EC%B9%98%EB%A3%8C%EC%9A%A9+TLR7+%ED%9A%A8%EB%8A%A5%EC%A0%9C+%EB%B0%8F+%EC%A1%B0%ED%95%A9%EB%93%A4&rft.inventor=HASSAN+HARIZ+ISKANDAR+BIN&rft.inventor=SAHIN+UGUR&rft.inventor=ROSEMANN+ROMAN&rft.inventor=STROBL+STEFAN&rft.date=2024-06-27&rft.externalDBID=A&rft.externalDocID=KR20240097833A